This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Honeywell (HON) to Gain From Business Strength Amid Risks
by Zacks Equity Research
Honeywell (HON) benefits from strength in its Aerospace unit, acquisitions and shareholder-friendly policies. Softness in the warehouse and workflow solutions unit is concerning.
Is Carlisle Companies (CSL) Stock Outpacing Its Conglomerates Peers This Year?
by Zacks Equity Research
Here is how Carlisle (CSL) and Griffon (GFF) have performed compared to their sector so far this year.
Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
by Zacks Equity Research
Strength in the Life Sciences segment augurs well for Danaher (DHR). The company's measures to reward its shareholders are promising.
Griffon (GFF) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Griffon (GFF) closed the most recent trading day at $66.83, moving +0.66% from the previous trading session.
GE Aerospace (GE) Opens Turkiye Technology Center in Istanbul
by Zacks Equity Research
GE Aerospace (GE) opens Istanbul facility, which will serve as its innovation hub to design and manufacture aircraft engines and related technologies.
Here's Why You Should Hold on to 3M (MMM) Stock Right Now
by Zacks Equity Research
3M (MMM) benefits from strength in electronics, and automotive and aerospace end markets. Also, the company's measures to reward its shareholders are encouraging.
Griffon (GFF) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Griffon (GFF) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Reasons Why ITT Stock Deserves to Be in Your Portfolio Now
by Zacks Equity Research
ITT stands to benefit from strength in its businesses, acquisitions and shareholder-friendly policies.
Zacks.com featured highlights include Griffon, Adtalem Global Education, HNI, Diebold Nixdorf and GigaCloud Technology
by Zacks Equity Research
Griffon, Adtalem Global Education, HNI, Diebold Nixdorf and GigaCloud Technology are part of the Zacks Screen of the Week article.
Honeywell (HON) Acquires Carrier's Global Access Solutions Unit
by Zacks Equity Research
Honeywell's (HON) acquisition of Global Access Solutions business is likely to enable it to expand its security products portfolio and boost its building automation segment.
5 Buy-Rated Stocks With Impressive Cash Flow Growth
by Moumita C. Chattopadhyay
Cash is the lifeblood of any business and provides vitality and strength to a company. So, companies with rising cash flows like GFF, ATGE, HNI, DBD and GCT are worth buying.
Here's Why Hold Strategy is Apt for Markel Group (MKL) Stock
by Zacks Equity Research
Markel Group (MKL) stands to gain from rate increases, strategic buyouts, new business volume, solid capital position and prudent capital deployment.
Here's Why You Should Add Carlisle (CSL) to Your Portfolio
by Zacks Equity Research
Carlisle (CSL) is set to gain from strength across its businesses, acquired assets and initiatives to drive operational excellence.
Are Conglomerates Stocks Lagging Carlisle Companies (CSL) This Year?
by Zacks Equity Research
Here is how Carlisle (CSL) and Griffon (GFF) have performed compared to their sector so far this year.
Reasons Why You Should Avoid Betting on GE Aerospace (GE)
by Zacks Equity Research
Increasing costs and unfavorable foreign-currency movement weigh on GE Aerospace's (GE) operations.
Zacks Industry Outlook Highlights Carlisle, Griffon and ITT
by Zacks Equity Research
Carlisle, Griffon and ITT are part of the Zacks Industry Outlook article.
3 Diversified Operations Stocks to Overcome Industry Headwinds
by Avisekh Bhattacharjee
Weakness in the manufacturing sector and supply chain issues dampen the prospects of the Zacks Diversified Operations industry. CSL, GFF and ITT are notable stocks in the industry.
Griffon Corporation (GFF) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Griffon (GFF) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Carlisle (CSL) Divests Interconnect Technologies Business
by Zacks Equity Research
Carlisle (CSL) divests the CIT segment to direct its focus to its core business and portfolio enhancement efforts.
Honeywell (HON) Rides on Business Strength Amid Headwinds
by Zacks Equity Research
Honeywell (HON) gains from strength in its Aerospace segment, buyouts and shareholder-friendly policies. Softness in the warehouse and workflow solutions unit remains concerning.
Danaher (DHR) Rides on Business Strength Amid Headwinds
by Zacks Equity Research
Danaher (DHR) gains from strength in academic and applied markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology unit is concerning.
Is Griffon (GFF) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Griffon (GFF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Does Griffon (GFF) Have the Potential to Rally 25.56% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 25.6% upside potential for Griffon (GFF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Can Griffon (GFF) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Griffon (GFF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why Griffon (GFF) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Griffon (GFF) have what it takes to be a top stock pick for momentum investors? Let's find out.